ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Psychoneuroendocrinology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0306-4530(84)90034-9PMID 6089243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mean 14.00–17.00 h plasma cortisol concentration and its relationship to the 1 mg‐dexamethasone suppression response in depressives and controls

  1984cited by this paper
• Corticotropin-releasing-factor induced pituitary-adrenal response in depression.

  1984cited by this paper
• Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia.

  1984cited by this paper
• Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.

  1984cited by this paper
• Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.

  1983cited by this paper
• Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects.

  1983cited by this paper
• Immediate and delayed alterations of adrenocorticotropin and cortisol nyctohemeral profiles after corticotropin-releasing factor in normal man.

  1983cited by this paper
• Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.

  1983cited by this paper
• The vasopressin receptor antagonist dPTyr(Me)AVP does not prevent stress-induced ACTH and corticosterone release

  1983cited by this paper
• Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.

  1983cited by this paper
• The dexamethasone suppression test in depressed patients: clinical and biochemical aspects.

  1983cited by this paper
• Plasma adrenocorticotropin and cortisol responses to intravenous injection of corticotropin-releasing factor in the morning and evening.

  1983cited by this paper
• Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

  1983cited by this paper
• Prediction of Clinical Course by Dexamethasone Suppression Test (DST) Response in Depressed Patients - Physiological and Clinical Construct Validity of the DST*

  1983cited by this paper
• Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.

  1983cited by this paper
• Increased sensitivity of the dexamethasone suppression test in depressed female patients based on multisteroid analysis.

  1983cited by this paper
• Isolation and sequence analysis of the human corticotropin‐releasing factor precursor gene.

  1983cited by this paper
• Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis

  1982cited by this paper
• Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement.

  1982cited by this paper
• CRF stimulates alpha-MSH secretion and cyclic AMP accumulation in rat pars intermedia cells.

  1982cited by this paper
• Dexamethasone suppression test in female patients with endogenous depression: determinations of plasma corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, cortisol and cortisone.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.

  1982cited by this paper
• The Dexamethasone Suppression Test for Melancholia

  1982cited by this paper
• Neuroendocrine abnormalities in depressive illness.

  1982cited by this paper
• In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone.

  1982cited by this paper
• Dexamethasone suppression of 11‐deoxycorticosterone, corticosterone and cortisol in depressed female patients and normal controls

  1982cited by this paper
• New hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man.

  1982cited by this paper
• CRF stimulates α-MSH secretion and cyclic AMP accumulation in rat pars intermedia cells

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper
• Cortisol secretion and dexamethasone response in depression.

  1981cited by this paper
• In vivo and in vitro release of ACTH by synthetic CRF.

  1981cited by this paper
• Simultaneous radioimmunoassay of plasma aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol and cortisone.

  1978cited by this paper
• Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

  1976cited by this paper
• Hydrocortisone suppression test for Cushing syndrome. Therapy with anticonvulsants.

  1974cited by this paper
• Adrenal cortical activity in pathological emotional states: a review.

  1966cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Sex-specific interactions between stress axis and redox balance are associated with internalizing symptoms and brain white matter microstructure in adolescents

  2024cites this paper
• The adrenal steroid profile in adolescent depression: a valuable bio-readout?

  2022cites this paper
• The glucocorticoid receptor in the limbic system of the human brain

  2016cites this paper
• Distribution of the glucocorticoid receptor in the human amygdala; changes in mood disorder patients

  2013cites this paper
• Stress response regulation in panic disorder.

  2012cites this paper
• Renin-Angiotensin-Aldosterone System: The Forgotten Stress Hormone System: Relationship to Depression and Sleep

  2012cites this paper
• Corticotropin releasing factor receptor antagonists for major depressive disorder

  2011cites this paper
• The many faces of depression in primary care

  2009cites this paper
• Reflexão THE MANY FACES OF DEPRESSION IN PRIMARY CARE

  2009cites this paper
• Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test.

  2009cites this paper
• 4. Hypercortisolemic Disorders

  2008cites this paper
• Major depression: emerging therapeutics.

  2008cites this paper
• Dihydropyridopyrazinones and dihydropteridinones as corticotropin-releasing factor-1 receptor antagonists: structure-activity relationships and computational modeling.

  2007cites this paper
• Neuroendocrine Markers of Stess Kenneth

  2007cites this paper
• Emerging Anxiolytics: Corticotropin‐Releasing Factor Receptor Antagonists

  2007cites this paper
• High-Affinity CRF1 Receptor Antagonist NBI-34041: Preclinical and Clinical Data Suggest Safety and Efficacy in Attenuating Elevated Stress Response

  2007cites this paper
• Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes?

  2007cites this paper
• Stress Neurobiology and Corticotropin-Releasing Factor

  2006cites this paper
• Funktionsprüfung von Schilddrüsenhormonrezeptoren im Verlauf einer antidepressiven Therapie

  2006influential citation
• Novel mechanisms to treat depression and anxiety: Will neuropeptide antagonists succeed?

  2006cites this paper
• The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

  2005cites this paper
• Emerging Treatments for Depression: Beyond the Monoamine Hypothesis

  2005cites this paper
• Nocturnal plasma levels of cytokines in healthy men

  2005cites this paper
• The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa

  2004cites this paper
• Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity

  2004cites this paper
• Pharmacoendocrinology of major depression

  2004cites this paper
• Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists.

  2004cites this paper
• Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

  2004cites this paper
• Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies.

  2003cites this paper
• Neuropeptide Alterations in Depression and Anxiety Disorders

  2003cites this paper
• The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review.

  2003cites this paper
• ACTH secretion prior to the discovery of cortieotropin releasing hormone (CRH) (L~cDON

  2002cites this paper
• The Neuroendocrinology of Affective Disorders

  2002cites this paper
• Corticotropin-releasing hormone in depression and post-traumatic stress disorder.

  2001cites this paper
• Cushing's Disease and Melancholia

  2001cites this paper
• 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist.

  2000cites this paper
• Increased diurnal plasma concentrations of cortisone in depressed patients.

  2000influential citation
• The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist.

  2000cites this paper
• The central mechanism of hypothalamic–pituitary– adrenocortical system hyperfunction in depressed patients

  2000cites this paper
• The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

  1999cites this paper
• Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load.

  1998cites this paper
• Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers.

  1998cites this paper
• Affective disorder subtyped by psychomotor symptoms, monoamine oxidase, melatonin and cortisol: identification of patients with latent bipolar disorder

  1998cites this paper
• Brain corticotropin-releasing factor immunoreactivity and receptors in five inbred rat strains: relationship to forced swimming behaviour.

  1997cites this paper
• [Reflections on the psychobiology of depression].

  1997cites this paper
• Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function.

  1996cites this paper
• Cortisol and adrenocorticotropin response to desmopressin in women with Cushing's disease compared with depressive illness.

  1996cites this paper
• Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders.

  1995cites this paper
• Self-esteem and neuroendocrine response to challenge: MacArthur studies of successful aging.

  1995cites this paper
• Chapter 3. Heterogeneity of Corticotropin Releasing Factor Receptors: Multiple Targets for the Treatment of CNS and Inflammatory Disorders

  1995cites this paper
• Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients.

  1994cites this paper
• Allostasis, amygdala, and anticipatory angst.

  1994cites this paper
• Evaluation of the hypothalamic-pituitary-adrenal axis: importance in steroid therapy, AIDS, and other stress syndromes.

  1994cites this paper
• The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

  1994cites this paper
• The Flinders sensitive line rats: a genetic animal model of depression.

  1993cites this paper
• Effect of the antidepressant tianeptine on the activity of the hypothalamo-pituitary-adrenal axis

  1993cites this paper
• Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.

  1993cites this paper
• Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients.

  1993cites this paper
• The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia.

  1992cites this paper
• Corticotropin-independent effect of ovine corticotropin-releasing hormone on cortisol release in man.

  1992cites this paper
• Comparison of time-integrated measurement of salivary corticosteroids by oral diffusion sink technology to plasma cortisol.

  1992cites this paper
• Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.

  1992cites this paper
• Adrenocorticotropin hormone, β-endorphin and cortisol responses to oCRF in melancholic patients

  1992cites this paper
• Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain.

  1991cites this paper
• Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity.

  1991cites this paper
• The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease.

  1991cites this paper
• Steroids and depression.

  1991cites this paper
• Multiple steroid hormone levels in depressed patients and normal controls before and after exogenous ACTH.

  1991influential citation
• Biological heterogeneity of melancholia: results of pattern recognition methods.

  1991cites this paper
• Erregungsungleichgewicht als mögliche Ursache seelischer Erkrankungen

  1991cites this paper
• Neuroendocrine markers of stress.

  1990cites this paper
• Cortisol Response to Corticotropin Releasing Hormone in Dexamethasone-Pretreated Patients with Depression

  1990cites this paper
• Diurnal variation of plasma corticosterone in depression.

  1990cites this paper
• Symptom profiles of biological markers in depression: a multivariate study.

  1990cites this paper
• Effects of metyrapone and dexamethasone upon pro-gamma-MSH plasma levels in depressed patients and healthy controls.

  1990cites this paper
• Chapter 23. Role of Corticotropin-Releasing Factor in Neuropsychiatric Disorders and Neurodegenerative Diseases

  1990cites this paper
• Suppressant effects of dexamethasone on the availability of plasma L‐tryptophan and tyrosine in healthy controls and in depressed patients

  1990cites this paper
• Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine.

  1989cites this paper
• Imbalance of Neuronal Excitability as a Cause of Psychic Disorder

  1989cites this paper
• Acute effects of alprazolam and adinazolam on the concentrations of corticotropin‐releasing factor in the rat brain

  1989cites this paper
• Plasma N-POMC, ACTH and cortisol following hCRH administration in major depression and dysthymia.

  1989cites this paper
• Biochemical studies in suicide victims: current findings and future implications.

  1989cites this paper
• Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary.

  1989cites this paper
• Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures.

  1989cites this paper
• Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients.

  1989cites this paper
• The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness.

  1989cites this paper
• Preclinical and Clinical Investigations of Corticotropin-Releasing Factor: Assessment of Its Role in Depressive Disorders

  1989cites this paper
• Elevated CSF CRF in suicide victims.

  1989cites this paper
• Cortisol Response to a Combined Dexamethasone‐Human Corticotrophin‐Releasing Hormone Challenge in Patients with Depression

  1989cites this paper
• CRF IN THE DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME: A COMPARISON WITH THE DEXAMETHASONE SUPPRESSION TEST

  1988cites this paper
• Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims.

  1988cites this paper
• Human corticotropin releasing hormone: clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls.

  1988cites this paper
• The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder.

  1988cites this paper
• The hypothalamic-pituitary-adrenocortical axis in major depression.

  1988cites this paper
• Past and present strategies of research on the HPA‐axis in psychiatry.

  1988cites this paper
• Response of ACTH and cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse.

  1988cites this paper
• Corticotropin-releasing factor and adrenal function in major depression

  1988cites this paper
• Implications of altered limbic‐hypothalamicpituitary‐adrenocortical (LHPA)‐function for neurobiology of depression

  1988cites this paper
• Preclinical and clinical studies with corticotropin-releasing factor: implications for affective disorders.

  1988cites this paper
• The oCRH stimulation test before and after clinical recovery from depression.

  1988cites this paper